ANAVEX LIFE SCIENCES CORP. Accretion Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Accretion Expense of $5.83 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2019-01-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2019-01-25
- ANAVEX LIFE SCIENCES CORP. accretion expense for the quarter ending 2016-09-30 was $4.66K, a 99.67% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. accretion expense for the quarter ending 2016-06-30 was $8.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. accretion expense for the quarter ending 2016-03-31 was $72.00, a 99.99% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. accretion expense for the quarter ending 2015-12-31 was $1.09K, a 84.62% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. accretion expense for fiscal 2016 was $5.83K, a 99.87% decline from fiscal 2015.
- ANAVEX LIFE SCIENCES CORP. accretion expense for fiscal 2015 was $4.52M, a 135.50% increase from fiscal 2014.
- ANAVEX LIFE SCIENCES CORP. accretion expense for fiscal 2014 was $1.92M.
- ANAVEX LIFE SCIENCES CORP. accretion expense for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month | Accretion Expense 89 month | Accretion Expense 92 month | Accretion Expense 95 month | Accretion Expense 98 month | Accretion Expense 101 month | Accretion Expense 104 month | Accretion Expense 107 month | Accretion Expense 110 month | Accretion Expense 113 month | Accretion Expense 116 month | Accretion Expense 119 month | Accretion Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $4.66K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $4.66K derived: sum of 2 quarters · filed 2019-01-25 | $4.74K derived: sum of 3 quarters · filed 2019-01-25 | $5.83K 10-K · filed 2019-01-25 | ||||||||||||
| 2016-06-30 | $8.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-07 | $80.00 derived: sum of 2 quarters · filed 2017-08-07 | $1.18K 10-Q · filed 2017-08-07 | $1.41M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||
| 2016-03-31 | $72.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $1.17K 10-Q · filed 2017-05-10 | $1.41M derived: sum of 3 quarters · filed 2017-12-11 | $4.02M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||
| 2015-12-31 | $1.09K 10-Q · filed 2017-02-07 | $1.41M derived: sum of 2 quarters · filed 2017-12-11 | $4.02M derived: sum of 3 quarters · filed 2017-12-11 | $4.51M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||
| 2015-09-30 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $4.02M derived: sum of 2 quarters · filed 2017-12-11 | $4.51M derived: sum of 3 quarters · filed 2017-12-11 | $4.52M 10-K · filed 2017-12-11 | ||||||||||||
| 2015-06-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | $3.10M derived: sum of 2 quarters · filed 2016-08-11 | $3.11M 10-Q · filed 2016-08-11 | $5.03M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2015-03-31 | $486.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $493.45K 10-Q · filed 2016-05-11 | $2.41M derived: sum of 3 quarters · filed 2016-12-14 | $2.41M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-12-31 | $7.12K 10-Q · filed 2016-02-08 | $1.92M derived: sum of 2 quarters · filed 2016-12-14 | $1.92M derived: sum of 3 quarters · filed 2016-12-14 | $1.92M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-09-30 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $1.92M derived: sum of 2 quarters · filed 2016-12-14 | $1.92M derived: sum of 3 quarters · filed 2016-12-14 | $1.92M 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $80.00 10-Q · filed 2014-08-13 | $1.09K derived: sum of 2 quarters · filed 2014-08-13 | $1.09K 10-Q · filed 2015-08-14 | $1.09K derived: sum of 4 quarters · filed 2015-02-17 | ||||||||||||
| 2014-03-31 | $1.01K 10-Q/A · filed 2014-05-30 | $1.01K 10-Q · filed 2015-05-14 | $1.01K derived: sum of 3 quarters · filed 2015-02-17 | $1.01K derived: sum of 4 quarters · filed 2015-02-17 | $2.18M 10-Q/A · filed 2014-05-30 | |||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-17 | $0.00 derived: sum of 2 quarters · filed 2015-02-17 | $0.00 derived: sum of 3 quarters · filed 2015-02-17 | $0.00 derived: sum of 4 quarters · filed 2015-02-17 | $2.17M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $0.00 derived: sum of 2 quarters · filed 2014-12-29 | $0.00 derived: sum of 3 quarters · filed 2014-12-29 | $0.00 10-K · filed 2014-12-29 | $2.17M 10-K · filed 2013-12-30 | |||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-13 | $0.00 derived: sum of 2 quarters · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | $0.00 derived: sum of 4 quarters · filed 2014-08-13 | $2.17M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 derived: sum of 3 quarters · filed 2014-05-30 | $15.29K derived: sum of 4 quarters · filed 2014-05-30 | $2.17M 10-Q · filed 2013-05-17 | |||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $15.29K derived: sum of 3 quarters · filed 2014-02-14 | $59.91K derived: sum of 4 quarters · filed 2014-02-14 | $2.17M 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $15.29K derived: sum of 2 quarters · filed 2013-12-30 | $59.91K derived: sum of 3 quarters · filed 2013-12-30 | $98.08K 10-K · filed 2013-12-30 | $2.17M 10-K · filed 2012-12-31 | |||||||||||
| 2012-06-30 | $15.29K 10-Q · filed 2013-08-14 | $59.91K derived: sum of 2 quarters · filed 2013-08-14 | $98.08K 10-Q · filed 2013-08-14 | $138.10K derived: sum of 4 quarters · filed 2013-08-14 | $2.17M 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | $44.61K 10-Q · filed 2013-05-17 | $82.79K 10-Q · filed 2013-05-17 | $122.81K derived: sum of 3 quarters · filed 2013-05-17 | $152.21K derived: sum of 4 quarters · filed 2013-05-17 | $2.16M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $38.17K 10-Q · filed 2013-02-14 | $78.19K derived: sum of 2 quarters · filed 2013-02-14 | $107.59K derived: sum of 3 quarters · filed 2013-02-14 | $107.59K derived: sum of 4 quarters · filed 2013-02-14 | $2.11M 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $40.02K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $69.42K derived: sum of 2 quarters · filed 2012-12-31 | $69.42K derived: sum of 3 quarters · filed 2012-12-31 | $69.42K 10-K · filed 2012-12-31 | $2.08M 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $29.40K 10-Q · filed 2012-08-17 | $29.40K derived: sum of 2 quarters · filed 2012-08-17 | $29.40K 10-Q · filed 2012-08-17 | $624.72K derived: sum of 4 quarters · filed 2012-08-17 | $2.04M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | $0.00 10-Q · filed 2012-05-15 | $595.32K derived: sum of 3 quarters · filed 2012-05-15 | $612.34K derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-14 | $595.32K derived: sum of 2 quarters · filed 2012-02-14 | $612.34K derived: sum of 3 quarters · filed 2012-02-14 | |||||||||||||
| 2010-09-30 | $595.32K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $612.34K derived: sum of 2 quarters · filed 2011-12-22 | $1.84M 10-K · filed 2011-12-22 | |||||||||||||
| 2010-06-30 | $17.02K 10-Q · filed 2011-08-12 | $1.24M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |